Jehan Z. Budak

Jehan Z. Budak

Auto-generated profile, based on publicly available information

Jehan Z. Budak

University of Washington School of Medicine

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2021 in Current HIV/AIDS Reports
Verified
Journal Article
Closed access
PDF file
JBJehan Z. Budak
Jehan Z. Budak
JSJohn D. Scott
John D. Scott
SDShireesha Dhanireddy
Shireesha Dhanireddy
BWBrian R. Wood
Brian R. Wood

16 June 2020 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
NMNandita S Mani
Nandita S Mani
JBJehan Z Budak
Jehan Z Budak
KLKristine F Lan
Kristine F Lan
CBChloe Bryson-Cahn
Chloe Bryson-Cahn
AZAllison Zelikoff
Allison Zelikoff
SCSeth A Cohen
Seth A Cohen
Background: Healthcare workers (HCWs) who serve on the front lines of the coronavirus disease 2019 (COVID-19) pandemic have been at increased risk for infection due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in some settings. Healthcare-acquired infection has been reported in similar epidemics, but there are limited data on the prevalence of COVID-19 among HCWs and their associated clinical outcomes in the United States. Methods: We established 2 high-throughput employee testing centers in Seattle, Washington, with drive-through and walk-through options for symptomatic employees in the University of Washington Medicine system and its affiliated organizations. Using data from these testing centers, we report the prevalence of SARS-CoV-2 infection among symptomatic employees and describe the clinical characteristics and outcomes among employees with COVID-19. Results: Between 12 March 2020 and 23 April 2020, 3477 symptomatic employees were tested for COVID-19 at 2 employee testing centers; 185 (5.3%) employees tested positive for COVID-19. The prevalence of SARS-CoV-2 was similar when comparing frontline HCWs (5.2%) with nonfrontline staff (5.5%). Among 174 positive employees reached for follow-up at least 14 days after diagnosis, 6 reported COVID-related hospitalization; all recovered. Conclusions: During the study period, we observed that the prevalence of positive SARS-CoV-2 tests among symptomatic HCWs was comparable to that of symptomatic nonfrontline staff. Reliable and rapid access to testing for employees is essential to preserve the health, safety, and availability of the healthcare workforce during this pandemic and to facilitate the rapid return of SARS-CoV-2–negative employees to work.

18 November 2020 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
SSSusan C. Van Schalkwyk
Susan C. Van Schalkwyk
EKElsie Kiguli-Malwadde
Elsie Kiguli-Malwadde
JBJehan Z. Budak
Jehan Z. Budak
MRMichael J.A. Reid
Michael J.A. Reid
MVMarietjie R. de Villiers
Marietjie R. de Villiers
Background: Recent increases in health professions education (HPE) research in sub-Saharan Africa (SSA), though substantial, have predominantly originated from single institutions and remained uncoordinated. A shared research agenda can guide the implementation of HPE practices to ultimately influence the recruitment and retention of the health workforce. Thus, the authors aimed to generate and prioritise a list of research topics for HPE research (HPER) in SSA.Methods: A modified Delphi process was designed to prioritise a shared agenda. Members of the African Forum for Research and Education in Health (AFREhealth) technical working group (TWG) were asked to first list potential research topics. Then, members of the same TWG and attendees at the annual AFREhealth academic symposium held in Lagos, Nigeria in August 2019 rated the importance of including each topic on a 3-point Likert scale, through two rounds of consensus seeking. Consensus for inclusion was predefined as ≥70% of respondents rating the topic as “must be included.”Results: Health professions educators representing a variety of professions and 13 countries responded to the survey rounds. Twenty-three TWG members suggested 26 initial HPER topics; subsequently 90 respondents completed round one, and 51 completed round 2 of the modified Delphi. The final list of 12 research topics which met predetermined consensus criteria were grouped into three categories: (1) creating an enabling environment with sufficient resources and relevant training; (2) enhancing student learning; and (3) identifying and evaluating strategies to improve pedagogical practice.Conclusions: Establishing research priorities for HPE is important to ensure efficient and appropriate allocation of resources. This study serves as a reminder of how the prevailing context within which HPE, and by implication research in the field, is undertaken will inevitably influence choices about research foci. It further points to a potential advocacy role for research that generates regionally relevant evidence.

3 May 2023 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
MTMatthew Triplette
Matthew Triplette
MBMeagan C. Brown
Meagan C. Brown
MSMadison Snidarich
Madison Snidarich
JBJehan Z. Budak
Jehan Z. Budak
NGNicholas Giustini
Nicholas Giustini
KCKristina Crothers
Kristina Crothers

15 March 2019 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
JMJennifer S Mulliken
Jennifer S Mulliken
CLCharles Langelier
Charles Langelier
JBJehan Z Budak
Jehan Z Budak
SMSteve Miller
Steve Miller
DDDavid Dynerman
David Dynerman
GMGregory P Melcher
Gregory P Melcher
Bergeyella cardium is a new species in the family Flavobacteriaceae that was recently described in 3 cases of native valve infective endocarditis. We report the first case of B. cardium prosthetic valve endocarditis, provide the first draft genome of this species, and review the microbiologic characteristics of this emerging pathogen.

29 April 2020 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
LWLindsey Ward
Lindsey Ward
MPMichael J Peluso
Michael J Peluso
JBJehan Z Budak
Jehan Z Budak
BEBrett M Elicker
Brett M Elicker
PCPeter V Chin-Hong
Peter V Chin-Hong
JMJennifer S Mulliken
Jennifer S Mulliken
We describe a case of opportunistic coinfections with Coccidioides immitis and Pneumocystis jirovecii following treatment with idelalisib, a phosphoinositide 3-kinase inhibitor, for chronic lymphocytic leukaemia. This is the first case of pulmonary coccidioidomycosis reported in association with idelalisib. We review challenges related to diagnosis of opportunistic infections in this context. This report illustrates (1) the uncommon occurrence of two opportunistic infections concurrently or in rapid succession, (2) the importance of maintaining a broad differential diagnosis in the setting of an atypical imaging finding, slow clinical response or when immunomodulatory drugs are used, and (3) the challenges associated with non-invasive serological testing in individuals with haematological malignancy on immunomodulatory therapy.